These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5576511)

  • 61. [Influence of the extent and dynamics of tuberculous changes and coexisting diseases on the seromucoid level in pulmonary tuberculosis patients].
    Rowińska E; Szulkin E; Styszewska H
    Gruzlica; 1965 Sep; 33(9):749-57. PubMed ID: 5859902
    [No Abstract]   [Full Text] [Related]  

  • 62. [Seroproteic picture in patients with pulmonary tuberculosis treated with D-2,2' (ethylendiimino) di-1-butanol (ethambutol)].
    De Simoni G
    Ann Ist Carlo Forlanini; 1966; 26(2):135-58. PubMed ID: 5954689
    [No Abstract]   [Full Text] [Related]  

  • 63. [Classification of destructive pulmonary tuberculosis into groups according to quantitative and qualitative characteristics with the aim of developing differentiated treatment methods].
    Smirnov GA; Valiev RSh
    Probl Tuberk; 1999; (5):11-4. PubMed ID: 10565207
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Iron metabolism in patients with different variants of pulmonary tuberculosis].
    Kaminskaia GO; Abdullaev RIu
    Probl Tuberk; 2002; (12):49-51. PubMed ID: 12611338
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Studies on the serum complement in pulmonary tuberculosis. 1. The complement level and serum protein pattern in healthy tuberculin-positive and -negative adults].
    Emura M
    Arerugi; 1967 Aug; 16(8):512-21. PubMed ID: 5584260
    [No Abstract]   [Full Text] [Related]  

  • 66. [Plasma antioxidative activity in patients with pulmonary tuberculosis].
    Kowalski J; Janiszewska-Drobińska B; Pawlicki L; Cegliński T; Irzmański R
    Pol Merkur Lekarski; 2004 Feb; 16(92):119-22. PubMed ID: 15176293
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Increased serum eosinophil cationic protein levels in familial Mediterranean fever.
    Konca K; Erken E; Ydrýsoglu S
    J Rheumatol; 1998 Sep; 25(9):1865-7. PubMed ID: 9733478
    [No Abstract]   [Full Text] [Related]  

  • 68. [Vitamin PP deficiency in patients with pulmonary tuberculosis of advanced and senile age].
    Sanitskii VI
    Probl Tuberk; 1971; 49(7):56-8. PubMed ID: 4259731
    [No Abstract]   [Full Text] [Related]  

  • 69. [Specific features of the macrophage formula of bronchoalveolar lavage in patients with destructive pulmonary tuberculosis].
    Lepekha LN; Lovacheva OV; Chernichenko NV; Erokhin VV; Seĭliev AA; Volchkov VA; Rozenberg OA
    Probl Tuberk Bolezn Legk; 2003; (12):17-21. PubMed ID: 15004966
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Haptoglobin content of the blood serum in patients with pulmonary tuberculosis].
    Radkevich RA; Kaminskaia GO
    Probl Tuberk; 1967; 45(12):43-8. PubMed ID: 5609891
    [No Abstract]   [Full Text] [Related]  

  • 71. [Differential pathogenetic therapy in the complex treatment of patients with destructive pulmonary tuberculosis].
    Molotkov VN; Ivaniuta OM; Bystritskaia VI; Mel'nik VN
    Probl Tuberk; 1982 Feb; (2):45-8. PubMed ID: 7063479
    [No Abstract]   [Full Text] [Related]  

  • 72. [Nutritional status and support in chronic intractable pulmonary tuberculosis].
    Yoneda T
    Kekkaku; 1996 Jan; 71(1):57-63. PubMed ID: 8808270
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Monocyte chemotactic protein-1 production in patients with active pulmonary tuberculosis and tuberculous pleurisy.
    Lee JS; Song CH; Lim JH; Lee KS; Kim HJ; Park JK; Paik TH; Jung SS; Jo EK
    Inflamm Res; 2003 Jun; 52(7):297-304. PubMed ID: 12861395
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cellular and humoral immunity to purified protein derivative (PPD) in PPD skin reactive and nonreactive patients with pulmonary tuberculosis: comparative analysis of antigen-specific lymphocyte proliferation and IgG antibodies.
    Boras Z; Juretić A; Rudolf M; Uzarević B; Trescec A
    Croat Med J; 2002 Jun; 43(3):301-5. PubMed ID: 12035136
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [A study of acid nuclease activity].
    Endakova EA; Novgorodtseva TP
    Lab Delo; 1991; (8):16-9. PubMed ID: 1724497
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Intrapulmonary pharmacokinetics of ofloxacin in drug-resistant tuberculosis.
    Chierakul N; Klomsawat D; Chulavatnatol S; Chindavijak B
    Int J Tuberc Lung Dis; 2001 Mar; 5(3):278-82. PubMed ID: 11326828
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Exacerbations and relapses after successful antibacterial therapy in initially diagnosed patients with destructive pulmonary tuberculosis].
    Afanas'eva GS
    Probl Tuberk; 1968; 46(10):50-4. PubMed ID: 5711694
    [No Abstract]   [Full Text] [Related]  

  • 78. [Relation between the efficacy of complex therapy of patients with destructive pulmonary tuberculosis and the duration of rifampicin administration].
    Sagalovich VIa; Manzhikova SR
    Probl Tuberk; 1984 Oct; (10):51-4. PubMed ID: 6514699
    [No Abstract]   [Full Text] [Related]  

  • 79. Circulating interleukin-18 and osteopontin are useful to evaluate disease activity in patients with tuberculosis.
    Inomata S; Shijubo N; Kon S; Maeda M; Yamada G; Sato N; Abe S; Uede T
    Cytokine; 2005 May; 30(4):203-11. PubMed ID: 15863395
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Comparative assessment of some diagnostic tests for determination of the activity of pulmonary tuberculosis].
    Voskresenskiĭ OP
    Probl Tuberk; 1967; 45(2):48-52. PubMed ID: 5605648
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.